Adjunctive Use of Statins for COVID-19

Mike Sathekge; Geert Byttebier; Bart De Spiegeleer; Bo Saxberg; Veronica Ueckermann; Luc Belmans; Myriam Alexander; David Fedson

doi:10.3390/jcm10071407

Adjunctive Use of Statins for COVID-19

J Clin Med. 2021 Apr 1;10(7):1407. doi: 10.3390/jcm10071407.

Authors

Mike Sathekge^{1

2}, Geert Byttebier³, Bart De Spiegeleer⁴, Bo Saxberg⁵, Veronica Ueckermann⁶, Luc Belmans⁷, Myriam Alexander⁸, David Fedson⁹

Affiliations

¹ Department of Nuclear Medicine, University of Pretoria & Steve Biko Academic Hospital, 0002 Pretoria, South Africa.
² Nuclear Medicine Research Infrastructure (NuMeRI), University of Pretoria, 0002 Pretoria, South Africa.
³ Bioconstat BV, 9000 Ghent, Belgium.
⁴ Drug Quality and Registration Group, Faculty of Pharmaceutical Sciences, Ghent University, 9000 Ghent, Belgium.
⁵ DDO Strategic Services, Tucson, AZ 85737-8488, USA.
⁶ Department of Internal Medicine, University of Pretoria & Steve Biko Academic Hospital, 0002 Pretoria, South Africa.
⁷ Medaman bv, 2440 Geel, Belgium.
⁸ Open Health, Marlow, Buckinghamshire SL7 2FF, UK.
⁹ 57, Chemin du Lavoir, 01630 Sergy Haut, France.

Abstract

The interaction between obesity, cardiometabolic disorders and COVID-19 represents a syndemic that requires both social intervention and a multipharmacological approach [...].

Publication types

Editorial